Octreotide Acetate (Sagent Pharmaceuticals)
Welcome to the PulseAid listing for the Octreotide Acetate drug offered from Sagent Pharmaceuticals. This Somatostatin Analog [EPC],Somatostatin Receptor Agonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Sagent Pharmaceuticals |
| NON-PROPRIETARY NAME: | octreotide acetate |
| SUBSTANCE NAME: | OCTREOTIDE ACETATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Somatostatin Analog [EPC],Somatostatin Receptor Agonists [MoA] |
| ROUTE: | INTRAVENOUS; SUBCUTANEOUS |
| DOSAGE FORM: | INJECTION, SOLUTION |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2013-12-15 |
| END MARKETING DATE: | 0000-00-00 |
Octreotide Acetate HUMAN PRESCRIPTION DRUG Details:
| Item Description | Octreotide Acetate from Sagent Pharmaceuticals |
| LABELER NAME: | Sagent Pharmaceuticals |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 50(ug/mL) |
| START MARKETING DATE: | 2013-12-15 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 25021-451_d943b4d8-9ebd-443f-818d-fdc16ec279ac |
| PRODUCT NDC: | 25021-451 |
| APPLICATION NUMBER: | ANDA090834 |
Other OCTREOTIDE ACETATE Pharmaceutical Manufacturers / Labelers:
